GLAXO WELLCOME SEREVENT WITH CORTICOSTEROIDS MAY SUBSTITUTE FOR A DOUBLE DOSE OF CORTICOSTEROIDS -- NHLBI GUIDELINES; CONTROL OF NOCTURNAL SYMPTOMS CITED
Executive Summary
Glaxo Wellcome's long-acting beta2-agonist Serevent is suitable for concomitant use with inhaled corticosteroids for the treatment of moderate persistent asthma, according to new asthma guidelines issued by the National Heart, Lung & Blood Institute. "Moderate persistent" asthma is a new category in the revised NHLBI guidelines.